New York State Common Retirement Fund’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,034
Closed -$31.6K 3290
2026
Q1
$31.6K Hold
5,034
﹤0.01% 2933
2025
Q4
$61.7K Hold
5,034
﹤0.01% 2843
2025
Q3
$103K Hold
5,034
﹤0.01% 2606
2025
Q2
$68K Hold
5,034
﹤0.01% 2854
2025
Q1
$43.6K Hold
5,034
﹤0.01% 2823
2024
Q4
$24.5K Hold
5,034
﹤0.01% 3011
2024
Q3
$38.9K Hold
5,034
﹤0.01% 2935
2024
Q2
$50.3K Buy
5,034
+1
+0% +$11 ﹤0.01% 3084
2024
Q1
$61.2K Sell
5,033
-7
-0.1% -$102 ﹤0.01% 2922
2023
Q4
$72.1K Sell
5,040
-35
-0.7% -$336 ﹤0.01% 2874
2023
Q3
$39.5K Buy
5,075
+44
+0.9% +$479 ﹤0.01% 3079
2023
Q2
$71.9K Sell
5,031
-7,117
-59% -$101K ﹤0.01% 3042
2023
Q1
$178K Sell
12,148
-17
-0.1% -$284 ﹤0.01% 2635
2022
Q4
$204K Sell
12,165
-87
-0.7% -$1.5K ﹤0.01% 2719
2022
Q3
$182K Sell
12,252
-144,802
-92% -$2.86M ﹤0.01% 2806
2022
Q2
$4.3M Buy
157,054
+4,295
+3% +$127K 0.01% 1265
2022
Q1
$5.76M Buy
152,759
+14,168
+10% +$627K 0.01% 1215
2021
Q4
$8.61M Sell
138,591
-14,908
-10% -$1.13M 0.01% 1070
2021
Q3
$13.1M Buy
153,499
+14,098
+10% +$884K 0.01% 882
2021
Q2
$8.63M Buy
139,401
+1,834
+1% +$93.3K 0.01% 1088
2021
Q1
$6.71M Buy
137,567
+123,567
+883% +$5.96M 0.01% 1134
2020
Q4
$436K Buy
14,000
+1,800
+15% +$44.1K ﹤0.01% 2417
2020
Q3
$254K Hold
12,200
﹤0.01% 2543
2020
Q2
$159K Hold
12,200
﹤0.01% 2746
2020
Q1
$111K Hold
12,200
﹤0.01% 2724
2019
Q4
$125K Hold
12,200
﹤0.01% 2934
2019
Q3
$177K Hold
12,200
﹤0.01% 2831
2019
Q2
$198K Buy
+12,200
New +$165K ﹤0.01% 2817

Other funds holding OPRX

New York State Common Retirement Fund's OPRX Position: Q2 2026 in Review

New York State Common Retirement Fund sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 5,034 shares — an estimated $31.6K sold.

New York State Common Retirement Fund first reported a position in OPRX in Q2 2019 and held it in 28 quarters. The position peaked at $13.1M in Q3 2021. 19 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • New York State Common Retirement Fund reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
  • New York State Common Retirement Fund sold 5,034 OptimizeRx shares in Q2 2026, an estimated $31.6K.
  • New York State Common Retirement Fund first reported a position in OptimizeRx in Q2 2019 and held it in 28 quarters.
  • New York State Common Retirement Fund's OptimizeRx position peaked at $13.1M in Q3 2021.
  • 19 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.